Novartis's total assets for Q4 2024 were $102.25B, a decrease of -1.23% from the previous quarter. NVS total liabilities were $58.12B for the fiscal quarter, a -3.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.